Astrazeneca Pharmaceuticals recalls Fasenra (benralizumab) Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility:
- Products
-
- Fasenra (benralizumab) Injection
- Company
- Astrazeneca Pharmaceuticals
- Where it was sold
-
Nationwide in the U.S
Nationwide
- Units affected
- 916 pre-filled syringes
- About this recall
- Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30